Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation

REFERENCES

1. 1.↵
   2. Louis DN,
   3. Perry A,
   4. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
2. 2.↵
   2. Fontebasso AM,
   3. Liu XY,
   4. Sturm D, et al

   . Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail. Brain Pathol 2013;23;210–16 doi:10.1111/bpa.12023 pmid:23432647

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Fontebasso AM,
   3. Schwartzentruber J,
   4. Khuong-Quang DA, et al

   . Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 2013;125:659–69 doi:10.1007/s00401-013-1095-8 pmid:23417712

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Hashizume R,
   3. Andor N,
   4. Ihara Y, et al

   . Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 2014;20:1394–96 doi:10.1038/nm.3716 pmid:25401693

   CrossRefPubMed
5. 5.↵
   2. Schwartzentruber J,
   3. Korshunov A,
   4. Liu XY, et al

   . Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012;482:226–31 doi:10.1038/nature10833 pmid:22286061

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Solomon DA,
   3. Wood MD,
   4. Tihan T, et al

   . Diffuse midline gliomas with histone H3–K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 2016;26:569–80 doi:10.1111/bpa.12336 pmid:26517431

   CrossRefPubMed
7. 7.↵
   2. Wu G,
   3. Broniscer A,
   4. McEachron TA, et al

   ; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012;44:51–53 doi:10.1038/ng.1102 pmid:22286216

   CrossRefPubMed
8. 8.↵
   2. Castel D,
   3. Philippe C,
   4. Calmon R, et al

   . Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 2015;30:815–27 doi:10.1007/s00401-015-1478-0 pmid:26399631

   CrossRefPubMed
9. 9.↵
   2. Bechet D,
   3. Gielen GG,
   4. Korshunov A, et al

   . Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 2014;128:733–41 doi:10.1007/s00401-014-1337-4 pmid:25200321

   CrossRefPubMed
10. 10.↵
    2. Jansen MH,
    3. Veldhuijzen van Zanten SE,
    4. Sanchez Aliaga E, et al

    . Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 2015;17:160–66 doi:10.1093/neuonc/nou104 pmid:24903904

    Abstract/FREE Full Text
11. 11.↵
    2. Jones C,
    3. Perryman L,
    4. Hargrave D

    . Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol 2012;9:400–13 doi:10.1038/nrclinonc.2012.87 pmid:22641364

    CrossRefPubMed
12. 12.↵
    2. Buczkowicz P,
    3. Bartels U,
    4. Bouffet E, et al

    . Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol 2014;128:573–81 doi:10.1007/s00401-014-1319-6 pmid:25047029

    CrossRefPubMedWeb of Science